Trial site
Dana-Farber Cancer Institute - Chestnut Hill
- 19running trials
- 4closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Bladder cancer5 trials
- Metastatic breast cancer5 trials
- Colorectal cancer4 trials
- Gastric and oesophageal cancer4 trials
- Childhood cancers3 trials
- Head and neck cancer3 trials
- Kidney cancer3 trials
- Melanoma3 trials
- Ovarian cancer3 trials
- Cervical cancer2 trials
- Endometrial cancer2 trials
- and 9 more
- Phase
- Phase 17 trials
- Phase 27 trials
- Phase 37 trials
- Phase 1/21 trial
- Status
- Active, not recruiting14 trials
- Recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Pfizer13 trials
- National Cancer Institute (NCI)4 trials
- Seagen, a wholly owned subsidiary of Pfizer4 trials
- Alliance for Clinical Trials in Oncology1 trial
- ECOG-ACRIN Cancer Research Group1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Active, not recruiting
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
Active, not recruiting
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Terminated
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026